A Conceptual Framework Integrating Epidemiologic Measurement, Digital Detection, and Equitable Delivery to Improve Early Detection, Reduce Health Disparities, and Strengthen Population Health Outcomes

period Cardiovascular deaths, United States 941,652 2022 Age-adjusted CVD mortality (overall) 224.3 per 100,000 Latest update Adults with obesity ~108 million (41.9%) Recent surveillance Adults with high blood pressure ~122 million (46.7%) Recent surveillance Adults with diabetes ~39 million (14.1%) Recent surveillance Adults living with heart failure ~6.7 million Latest update Projected heart failure prevalence ~8.7 million 2030 Lifetime risk of heart failure ~24% Latest update Indicator Value Reference period Share of global deaths from CVD ~27% Latest update Values are drawn from recent national and society surveillance reports and are presented for orientation; see the body text for sources and interpretation. 3. Health Disparities and the Social Determinants of Cardiovascular Risk The aggregate burden described above is not borne equally. Cardiovascular disease is among the most unequally distributed of all major health conditions, and the patterning of that inequality by race, ethnicity, sex, geography, and socioeconomic position is both stark and persistent. A prevention agenda that aspires to strengthen population health cannot treat these disparities as a secondary concern; they are the principal reason that aggregate progress has stalled, because the gains achieved in advantaged groups are offset by stagnation or deterioration among those who have been historically underserved. 3.1 Disparities by Race, Ethnicity, and Sex The mortality data make the gradient explicit. Against an overall age-adjusted cardiovascular mortality rate of approximately 224.3 per 100,000, the rate among non-Hispanic Black men reaches roughly 379.7 per 100,000, while the rate among Asian women is approximately 104.9 per 100,000 (Martin et al., 2025). A difference of this magnitude, more than threefold between the highest and lowest subgroups, cannot be explained by biology or individual behavior alone; it reflects the cumulative imprint of differential exposure to risk, differential access to detection and treatment, and the structural conditions that shape both. Risk-factor prevalence follows the same contours. Black women report the highest prevalence of obesity, at approximately 57.9 percent, and the highest prevalence of high blood pressure, at approximately 58.4 percent, among the groups examined, while Hispanic men report the highest prevalence of diabetes, at approximately 14.5 percent (Martin et al., 2025). The consequences propagate through to mortality: hypertension-related death among Black men is more than double that observed among non-Hispanic White men, at roughly 67.3 versus 33.3 per 100,000 (Martin et al., 2025). These are not isolated statistics but a coherent pattern in which elevated exposure, undertreatment, and excess mortality compound one another within the same populations. 3.2 Geographic and Rural Disparities Disparities are spatial as well as demographic. Cardiovascular mortality varies substantially across regions and between urban and rural communities, with rural populations frequently experiencing higher rates of both risk factors and death. In the rural South in particular, high concurrent burdens of hypertension and poverty interact to widen the gap between Black and White adults, a pattern that has motivated dedicated multilevel interventions targeting the structural barriers to healthy nutrition and physical activity (Havranek et al., 2015). Geographic disparity is consequential for prevention strategy because it implies that uniform, clinic-centered approaches will systematically underserve the very communities with the greatest need, and that detection and delivery must be designed to reach beyond well-resourced metropolitan health systems. Expanding diagnostic capacity into underserved and rural regions through deliberate investment in laboratory and diagnostic infrastructure has been characterized as a public health intervention in its own right, capable of widening access where conventional clinical pathways are sparse (Aminu-Ibrahim et al., 2020; Aminu-Ibrahim and Ogbete, 2023). 3.3 Maternal Cardiovascular Health Cardiovascular disease is now the leading cause of maternal mortality, a fact that links cardiovascular prevention directly to reproductive health and to the life-course origins of risk (Martin et al., 2025). The disparities observed in the general population are amplified in the peripartum period, and the recognition that pregnancy functions as a cardiovascular stress test has opened a window for earlier identification of women at elevated long-term risk. Tailoring interventions to high-risk groups early, including in the perinatal period, offers a means of reducing both immediate maternal mortality and downstream cardiovascular events across the subsequent decades (Martin et al., 2025). Integrative models of maternal health that explicitly address socioeconomic inequities in rural populations illustrate one approach to intervening within this window (Akinse et al., 2023). 3.4 Structural and Social Determinants Underlying these patterns are the social and structural determinants of health: the conditions in which people are born, live, work, and age, and the systems that distribute resources and exposures among them (Marmot, 2005). Reducing cardiovascular disparities will require deliberate effort to adopt evidence-based interventions, particularly those that address social determinants, within historically marginalized communities (American Heart Association, 2024; Havranek et al., 2015). Food cost and the availability of nutritious food, the built environment and its support or obstruction of physical activity, exposure to chronic stressors, and access to consistent primary care all operate as determinants of cardiovascular risk that lie outside the conventional clinical encounter. A prevention program that confines itself to the clinic, therefore, addresses only the most distal expression of a problem whose roots are social. The implication for the present agenda is that measurement must capture social context, detection must extend into community settings, and delivery must engage the structures that produce risk. The reach of these determinants across the prevention pathway is not unique to cardiovascular disease; systematic review in other domains of public health has linked structural and social determinants to disparities in the uptake of testing and engagement with treatment (Anioke et al., 2024), reinforcing the case that they operate throughout the pathway rather than at its clinical endpoint alone. Table 2 summarizes the principal disparities that any equitable prevention strategy must confront. Table 2. Selected disparities in cardiovascular mortality and risk-factor prevalence. Domain Observed disparity Age-adjusted CVD mortality Non-Hispanic Black men ~379.7 per 100,000 versus Asian women ~104.9 per 100,000 Sex difference in CVD mortality Men ~273.9 versus women ~183.1 per 100,000 Obesity prevalence Highest among Black women (~57.9%) High blood pressure prevalence Highest among Black women (~58.4%) Diabetes prevalence Highest among Hispanic men (~14.5%) Hypertension-related mortality Black men ~67.3 versus White men ~33.3 per 100,000 Maternal mortality Cardiovascular disease is the leading cause Domain Observed disparity Geography Elevated burden in rural regions, notably the rural South Estimates are drawn from recent national surveillance and are intended to illustrate the structure of inequality rather than to provide exhaustive subgroup detail. 4. Translational Digital-Health Innovation for Early Detection 4.1 The Case for Earlier Detection Much of the residual cardiovascular burden accrues during a long, clinically silent phase in which subclinical disease advances undetected. By the time a person presents with an event, the opportunity for the least costly and most effective prevention has frequently passed. The strategic value of digital-health innovation lies in its capacity to compress this latency by moving detection earlier in the natural history and by extending it beyond the episodic clinical encounter into the continuous fabric of daily life. Atrial fibrillation provides the clearest illustration. It is the most common sustained arrhythmia, it materially elevates the risk of stroke and heart failure, and it is frequently paroxysmal and asymptomatic, which renders it poorly captured by the intermittent monitoring on which conventional practice relies (Perez et al., 2019). A technology that can surveil rhythm continuously and unobtrusively therefore addresses a detection gap that conventional cardiology has been unable to close. 4.2 Wearable Biosensors and Consumer Devices Consumer wearable devices have evolved from fitness accessories into instruments with credible clinical relevance. Large-scale studies have demonstrated that smartwatches and fitness trackers, using photoplethysmography to sense pulse irregularity and, in newer devices, single-lead electrocardiography, can identify previously undiagnosed atrial fibrillation in free-living populations. A study of a wrist-worn device in a large population showed that algorithmic detection of irregular rhythm could flag undiagnosed atrial fibrillation and prompt confirmatory evaluation (Lubitz et al., 2022), building on earlier large-scale work that established the feasibility of smartwatch-based screening at population scale (Perez et al., 2019). The defining advantage of these devices is reach: they are already worn by tens of millions of people, they operate continuously, and they generate longitudinal physiological data outside any clinical setting, thereby touching populations that present to formal care infrequently or late. That reach is accompanied by genuine limitations that responsible translation must confront. Diagnostic performance varies considerably across devices, algorithms, and the populations in which they are used. Comparative validation against twelve-lead electrocardiography, the established reference standard, has shown that consumer devices can achieve high accuracy under favorable conditions but that performance degrades with motion, with certain skin tones and perfusion states relevant to photoplethysmography, and with the comorbidity profiles encountered in real-world ambulatory practice (Wouters et al., 2025). A device that performs well in a supervised validation cohort may perform unevenly across the heterogeneous population a prevention program intends to serve, and that unevenness is itself an equity concern, since uneven sensor performance can widen rather than narrow disparities if it is not measured and corrected. 4.3 Artificial Intelligence and the Electrocardiogram A parallel and arguably more transformative development is the application of deep learning to the electrocardiogram. Neural networks trained on large labeled datasets have demonstrated the capacity to extract signal from the standard electrocardiogram that exceeds what expert human readers can perceive, including the detection of conditions that are not conventionally diagnosable from the tracing at all. Models have been developed to identify left ventricular systolic dysfunction from a routine electrocardiogram obtained during normal sinus rhythm, effectively using the inexpensive and ubiquitous electrocardiogram as a screening test for a condition that otherwise requires echocardiography (Attia et al., 2019). The broader field of artificial-intelligence-enhanced electrocardiography has extended to the prediction of incident atrial fibrillation, the estimation of physiologic age, and the stratification of risk for a range of structural and arrhythmic conditions (Siontis et al., 2021). These advances form part of a broader transformation in which machine learning is reshaping diagnosis and prediction across medicine (Topol, 2019; Rajkomar et al., 2019). Recent work has paired these predictive models with explainability techniques that identify the regions of the electrocardiographic waveform driving a given prediction, an advance that addresses one of the principal barriers to clinical adoption. Models predicting the onset of paroxysmal atrial fibrillation from a normal sinus-rhythm tracing, for example, have combined strong discrimination with the localization of the morphological features that inform their predictions, making the basis of a prediction inspectable rather than opaque (Siontis et al., 2021). The convergence of single-lead acquisition, mobile platforms, and interpretable algorithms suggests a near-term future in which sophisticated cardiovascular screening is delivered through devices that already reside in patients' pockets and on their wrists, at marginal cost approaching zero and with a geographic reach that no clinic network can match. 4.4 Remote Monitoring and Risk Stratification Beyond episodic detection, digital platforms enable continuous remote monitoring that can transform the management of established risk. Connected blood-pressure cuffs, glucose sensors, and weight scales, integrated with clinical decision support, allow the longitudinal tracking of risk factors between visits and the early identification of deterioration. When such data are coupled with risk-stratification algorithms that triage attention toward those at highest near-term risk, the result is a model of prevention that is anticipatory rather than reactive. The promise is substantial, but its realization depends on integration: a stream of physiological data that is not connected to a responsive clinical workflow generates alerts without action, and may increase burden without improving outcomes. The decisive question for translation is therefore not whether a device can measure a parameter accurately, but whether the measurement reliably triggers an effective and equitable response. Decision-support systems that apply artificial intelligence to healthcare operations and resource planning illustrate one mechanism for this, extending analytic tools beyond detection into the allocation of limited clinical capacity toward those at greatest need (Adelanwa et al., n.d.). The principle of moving identification upstream and into the community is well established in adjacent areas of public health, where predictive community-based surveillance models support the early detection of emerging threats (Eweama et al., 2021) and artificial-intelligence-enhanced surveillance supports the monitoring of transmission dynamics at population scale (Ohanebo et al., 2025); the transferable lesson is that continuous, population- facing detection complements rather than replaces episodic clinical assessment. The same upstream shift is visible within chronic disease itself, where AI-driven systems have been developed specifically for the early detection of non-communicable diseases (Afrihyia et al., 2023), and where natural-language processing applied to social-media data has been explored as a complementary stream for public health surveillance (Atakpa et al., 2023). 4.5 Validation, Regulation, and Evidentiary Standards The translation of digital tools from technical demonstration to clinical and population use rests on the rigor of their validation. The evidentiary standard appropriate to a screening technology intended for broad deployment is demanding: it requires prospective evaluation against established reference standards, assessment of diagnostic performance across the full diversity of the intended population, demonstration that detection leads to improved outcomes rather than merely to increased diagnosis, and transparent reporting of failure modes. Narrative and systematic reviews of the field have repeatedly observed that the breadth and quality of the supporting evidence remain variable, and that much of the published work has been conducted in selected populations under supervised conditions that may not reflect real-world use (Wouters et al., 2025). A prevention program that intends to incorporate these tools must therefore treat validation not as a completed prerequisite but as an integral and ongoing component of the research itself, generating the population-specific evidence that responsible deployment requires. 5. Scalable Implementation Frameworks 5.1 The Research-to-Practice Gap The most sobering fact in prevention is that the interventions known to work frequently fail to reach the people who would benefit. The gap between efficacy demonstrated in controlled research and effectiveness achieved in routine practice is wide, durable, and unequally distributed, and it is the principal reason that decades of cardiovascular discovery have not translated into proportionate population gains. Closing this gap is the province of implementation science, the systematic study of methods to promote the adoption and integration of evidence-based practices into routine care and policy. Because implementation science is organized around stakeholder engagement and grounded in explicit theoretical frameworks, it is well suited to addressing the research-to-practice gap, yet guidance on how best to deploy it specifically to advance cardiovascular health equity has historically been limited (American Heart Association, 2024). 5.2 RE-AIM and the Consolidated Framework for Implementation Research Two frameworks anchor much of contemporary implementation work in cardiovascular prevention. The RE-AIM framework directs attention to five dimensions that jointly determine population impact: reach, the proportion and representativeness of the people an intervention engages; effectiveness, its effect on outcomes; adoption, its uptake by settings and providers; implementation, the fidelity and consistency of its delivery; and maintenance, its sustainment over time (Glasgow et al., 1999). The framework's central insight is that an intervention's population impact is the product of these dimensions, not of effectiveness alone, so that a highly effective program with poor reach may achieve less than a modestly effective program that reaches many. The Consolidated Framework for Implementation Research complements this outcome-oriented lens with a determinant-oriented one, cataloguing the contextual factors across the intervention, the inner and outer settings, the individuals involved, and the implementation process that facilitate or obstruct success (Damschroder et al., 2009), a framework subsequently updated to reflect accumulated user experience (Damschroder et al., 2022). Applied together, these frameworks structure both the design and the evaluation of prevention programs. Process evaluations of comprehensive cardiovascular prevention initiatives in primary care have used them in tandem to identify the facilitators and barriers that determine whether a program reaches vulnerable populations, is adopted by providers, is delivered with fidelity, and is maintained, and to link those determinants to concrete implementation strategies, drawing on standardized compilations of such strategies (Powell et al., 2015; Glasgow et al., 1999). Complementary process and phased frameworks, including the model known by the acronym PRISM and the exploration, preparation, implementation, and sustainment framework, extend this toolkit to the planning of staged rollout and long-term sustainment (Feldstein and Glasgow, 2008; Aarons et al., 2011). Despite their demonstrated utility, these frameworks remain underutilized in cardiovascular prevention relative to their potential (Damschroder et al., 2022). 5.3 Community Health Worker Models Among the delivery models with the strongest evidence for extending reach into underserved populations is the community health worker model, in which trained members of a community deliver screening, education, counseling, and navigation support outside conventional clinical settings. The evidence for this approach in cardiovascular prevention is substantial. A large cluster- randomized community-based trial demonstrated that an intervention led by nonphysician health workers achieved blood-pressure control in approximately 69 percent of participants, compared with roughly 30 percent under usual care, a difference of striking magnitude (Schwalm et al., 2019). Community-based screening, counseling, and home-based follow-up models have shown consistent value for hypertension control across diverse settings, and they offer a cost-effective pathway to overcoming access barriers and advancing equity precisely because they meet people where they are rather than requiring them to present to a clinic (Schwalm et al., 2019). Community engagement has repeatedly emerged as a decisive determinant of success. Programs that mobilize local organizations, schools, workplaces, and health services tend to achieve greater reach and more durable impact than those that rely solely on provider-initiated approaches, suggesting that sustainable improvement in cardiovascular health requires broad social engagement alongside clinical action (Frieden, 2010). Implementation studies of community health worker programs in varied international settings have used the frameworks described above to surface the factors that govern their scalability and sustainment, including workforce capacity, the strength of the link between community and formal health care, and the alignment of financial and regulatory structures (Damschroder et al., 2009). 5.4 Health-System Integration and Team-Based Care Community-based and clinic-based approaches are most powerful in combination. Clinical programs achieve larger individual-level effects but are constrained by limited reach, while community programs achieve broader reach with more modest individual effects; an integrated model that links the two can capture the strengths of each (Glasgow et al., 1999), a contrast that mirrors the observation, central to the health impact pyramid, that interventions altering the conditions of daily life reach more people than those requiring repeated individual clinical action (Frieden, 2010). Team-based care, in which the management of cardiovascular risk is distributed across physicians, nurses, pharmacists, and community health workers operating under shared protocols, has a robust evidence base for improving blood-pressure control and for reducing disparities. Nurse-led interventions for community-dwelling older adults provide further evidence that appropriately trained nonphysician personnel can improve health outcomes outside the conventional clinical setting (Obi et al., 2025). Realizing these models at scale depends on conditions that the implementation literature identifies consistently: the prioritization of prevention within the organizational vision, the expansion and upskilling of nonphysician roles, compatibility with existing workflows, supportive financial and regulatory frameworks, and a strong link between the health system and the community it serves (Damschroder et al., 2022). Realizing detection and delivery at scale also depends on the physical and organizational capacity to provide them; standardized models for designing and scaling diagnostic facilities, together with resilience planning for national diagnostic systems under conditions of public health stress, address the infrastructural dimension of equitable reach (Ogbete et al., 2026; Aminu-Ibrahim et al., 2025). The substance that such systems deliver rests on a broad evidence base for behavioral and lifestyle modification, including dietary patterns, physical activity, and stress reduction (Abah et al., 2025a), plant-based dietary approaches (David et al., 2025), and anti-inflammatory nutritional strategies (Okwah et al., 2026), with behavioral frameworks such as the theory of planned behavior informing the design of interventions intended to sustain such change across diverse contexts (Fehintola et al., 2024). Coordinated project-management approaches to multisite implementation within United States health systems, although developed in adjacent clinical domains, offer transferable lessons for delivering these programs reliably at scale (Omo Enabulele et al., 2025). Delivery further depends on communication and on system resilience: digital public health communication models have been shown to improve the uptake of preventive services in other domains (Anioke et al., 2023), and frameworks developed for infectious-disease preparedness offer transferable lessons for strengthening the resilience of the systems through which prevention is delivered (Eweama et al., 2019). 5.5 Equity-Centered Implementation If implementation is approached naively, it can widen disparities rather than narrow them, because new interventions are frequently adopted first and most thoroughly by the better-resourced settings and populations that need them least. Avoiding this outcome requires that equity be designed into implementation from the outset rather than appended as an afterthought. This entails the deliberate prioritization of reach among marginalized populations, the adaptation of interventions to context through participatory methods that engage the affected communities in co-design, and the explicit measurement of differential reach, adoption, and effect across subgroups. Adaptations of established frameworks that foreground structural factors, including approaches that bring an explicit focus on racism and structural disadvantage into the assessment of context, have been advanced precisely to ensure that implementation serves equity rather than undermining it (American Heart Association, 2024). Table 3 summarizes the frameworks and delivery models on which a scalable, equitable prevention strategy can draw. Table 3. Implementation frameworks and delivery models relevant to scalable cardiovascular prevention. Framework or model Core contribution to scalable, equitable prevention RE-AIM Defines population impact as a function of reach, effectiveness, adoption, implementation, and maintenance, not effectiveness alone. CFIR Catalogues contextual determinants across intervention, settings, individuals, and process that facilitate or obstruct uptake. PRISM and EPIS Support phased planning, contextual integration, and long-term sustainment of programs. Framework or model Core contribution to scalable, equitable prevention Community health worker models Extend reach into underserved populations; demonstrated large gains in blood-pressure control versus usual care. Team-based care Distributes risk management across a coordinated workforce under shared protocols to improve control and reduce disparities. Equity-centered adaptation Designs reach, co-design, and subgroup measurement to ensure implementation narrows rather than widens disparities. The frameworks are complementary rather than competing; an integrated program draws on several simultaneously. 6. The Conceptual Framework 6.1 Purpose and Organizing Premise The preceding sections establish a clear logic. The cardiovascular burden is large, growing, and unequally distributed; effective interventions exist but reach the population poorly; digital tools could move detection earlier and extend its reach; and implementation science provides the means to deliver those tools and interventions equitably at scale. This paper's central contribution is to organize that logic into a conceptual framework, termed here the Measurement, Detection, and Delivery framework for equitable cardiovascular prevention. A conceptual framework does not itself generate data. Its function is to identify the constructs that matter, to specify the relationships among them, and to make explicit the propositions that follow, so that research, policy, and practice can be designed coherently and tested systematically. The MDD framework is offered in that spirit, as a structure for thinking about cardiovascular prevention rather than as a study to be conducted. The framework rests on a single organizing premise: that the persistence of the cardiovascular burden is principally a problem of distribution and delivery rather than of discovery. The science of which interventions lower cardiovascular risk is mature, yet those interventions reach the populations of greatest need late, partially, or not at all. The framework therefore foregrounds three functions, each supplied by a distinct discipline, and treats their integration, rather than the separate optimization of any one, as the locus of population impact. The constructs are deliberately defined at the level of function rather than of any specific tool or dataset, so that the framework remains applicable as particular technologies and methods evolve . 6.2 The Three Core Constructs Measurement, supplied by epidemiology, is the function of locating cardiovascular risk precisely in time, place, and population. It encompasses the estimation of risk-factor prevalence and co- occurrence across the cardiovascular-kidney-metabolic continuum, the mapping of mortality and morbidity at fine demographic and geographic resolution, and the identification of the social and structural determinants that concentrate risk within particular groups. Measurement defines where the burden lies, which populations and life-course stages offer the greatest leverage, and the baselines against which progress is judged. Detection, supplied by translational digital-health innovation, is the function of identifying disease and elevated risk earlier in the natural history and in a larger share of the population than conventional clinical pathways achieve. It encompasses wearable biosensors, artificial intelligence applied to the electrocardiogram, and remote monitoring, and its defining contribution is reach: the capacity to extend identification beyond the episodic clinical encounter into the continuous fabric of daily life and into settings that formal care serves poorly. Detection converts the risk that measurement locates into actionable identification of individuals. Delivery, supplied by implementation science, is the function of converting detection into effective and equitable action. It encompasses the established frameworks for reach, adoption, fidelity, and sustainment, community-anchored and team-based delivery models, and the organizational and infrastructural capacity required to act on what detection reveals. Delivery is the construct that determines whether identification produces benefit, and it is the construct at which the research-to-practice gap most often defeats prevention. 6.3 The Integrating Mechanism: Sequence and Feedback The three constructs are arranged not as independent pillars but as a sequence linked by feedback. In the forward direction, measurement directs detection toward the populations and settings of greatest need; detection informs delivery by identifying the individuals who require action; and delivery produces population health outcomes. In the reverse direction, outcomes and the data newly generated through detection and delivery return to refine measurement and to recalibrate detection, so that the system improves with use rather than remaining static. This feedback is the feature that distinguishes the framework from a simple linear pipeline: a measurement that is never updated by downstream data grows stale, and a detection tool that is never re-evaluated against outcomes drifts. Figure 1 represents the framework, including the cross-cutting role of equity described below. Figure 1. The Measurement, Detection, and Delivery framework for equitable cardiovascular prevention. Equity operates as a cross-cutting principle; the dashed arrow denotes the feedback through which outcomes and new data refine measurement and detection. 6.4 Equity as a Cross-Cutting Construct Equity is not a fourth stage appended to the sequence but a property that must hold across all three constructs simultaneously. Within measurement, equity requires that data adequately represent the populations of greatest need, since estimates derived from unrepresentative data misdirect the entire system. Within detection, equity requires that diagnostic performance be comparable across subgroups, since a tool that performs unevenly will widen disparities even as it raises aggregate detection. Within delivery, equity requires that reach extend to the underserved, since an intervention adopted first by the best-resourced settings entrenches the very inequalities the framework seeks to reduce. Treating equity as cross-cutting reflects the central empirical fact established earlier: because the aggregate burden is sustained by disparity, the framework's impact on the aggregate is largely determined by its impact on the most burdened groups. 6.5 Propositions The framework yields a set of propositions that are stated to be testable, so that the structure can be evaluated and, where necessary, revised rather than merely asserted. They are offered as the framework's principal falsifiable claims. • Proposition 1 (Integration). Population-level impact is a multiplicative rather than additive function of measurement precision, detection reach, and delivery fidelity, such that weakness in any one construct constrains the impact of the whole. • Proposition 2 (Earlier detection). Moving detection earlier in the cardiovascular-kidney- metabolic continuum, toward the stages at which measurement locates tractable risk, yields greater marginal benefit than equivalent investment at the stage of clinical disease. • Proposition 3 (Primacy of reach). Where detection and delivery extend reach to underserved populations, interventions of modest per-person effect produce larger population gains than higher-efficacy interventions confined to advantaged groups. • Proposition 4 (Feedback). Prevention systems that route outcome and performance data back into measurement and detection improve over time, whereas open-loop deployments stagnate or drift. • Proposition 5 (Equity dependence). Gains in aggregate outcomes are sustained only when detection performs equitably across subgroups and delivery reaches those subgroups; inequitable detection or delivery widens disparities even as aggregate metrics appear to improve. • Proposition 6 . The reach of digital detection and remote monitoring is bounded by the trustworthiness of data governance; in the absence of trust, the populations of greatest need participate least, undermining both equity and validity. Table 4 summarizes the three constructs, their disciplinary sources, their core functions, and illustrative inputs, providing a compact reference for the framework as a whole. Table 4. The three constructs of the Measurement, Detection, and Delivery framework. Construct Disciplinary source Core function Illustrative inputs Measurement Epidemiology Locate risk precisely in time, place, and population Surveillance data, vital statistics, electronic records, determinant modeling Detection Digital-health innovation Identify disease and risk earlier and in more people Wearable biosensors, AI- enhanced electrocardiography, remote monitoring Construct Disciplinary source Core function Illustrative inputs Delivery Implementation science Convert detection into effective, equitable action RE-AIM, CFIR, community health worker and team-based models, diagnostic infrastructure Equity (cross- cutting) Spans all constructs Ensure representativeness, fair performance, and reach for the underserved Subgroup measurement, equity-centered adaptation, participatory co-design, trustworthy governance The constructs are defined at the level of function so that the framework remains applicable as specific tools and methods evolve. 6.6 Relationship to Existing Frameworks The MDD framework does not displace the established frameworks on which it draws; it situates them in relation to one another and supplies the connective structure they individually lack. RE- AIM specifies the dimensions along which any single intervention should be evaluated for population impact (Glasgow et al., 1999), and the Consolidated Framework for Implementation Research catalogues the contextual determinants of successful implementation (Damschroder et al., 2009; Damschroder et al., 2022); both operate principally within the delivery construct and constitute, in effect, the framework's account of how delivery succeeds. The American Heart Association's construct of cardiovascular health, which defines the modifiable behaviors and clinical factors that compose ideal cardiovascular health, specifies much of what measurement should track and what delivery should seek to change (Lloyd-Jones et al., 2022). The cardiovascular-kidney-metabolic staging construct describes the disease continuum along which earlier detection is most valuable (Ndumele et al., 2023), and the health impact pyramid articulates why interventions with broad reach outperform those dependent on repeated individual action (Frieden, 2010), a principle the framework encodes in its primacy-of-reach proposition. The distinct contribution of the MDD framework is to bind these complementary accounts of measurement, detection, and delivery into a single structure linked by feedback and governed throughout by equity, so that the leverage points each existing framework illuminates can be pursued in concert rather than in isolation. 7. Operationalizing the Framework A conceptual framework earns its value by guiding inquiry and practice, and so it is useful to indicate how the MDD framework can be operationalized and how its propositions might be tested. This section sketches that operationalization at the level of each construct and of the framework as a whole, without prescribing a single study design, since the framework is intended to organize many such designs rather than to specify one. 7.1 Operationalizing Measurement The measurement construct is operationalized through population-representative data resources that permit the estimation of risk-factor prevalence, mortality, and their determinants across demographic and geographic strata. Suitable resources include national health and nutrition surveillance, vital-statistics and death-index linkages, electronic health record networks that aggregate clinical data across diverse systems, and administrative claims that capture utilization and outcomes at scale. Consistent with the framework's treatment of equity as cross-cutting, operationalization prioritizes data with adequate representation of the subgroups of interest, since the precision of subgroup estimates depends directly on adequate sample within each stratum, and underrepresentation of marginalized populations is itself a recognized barrier to equitable evidence. The co-occurrence and staging of risk across the cardiovascular-kidney-metabolic continuum are modeled to identify the configurations most amenable to early intervention, and associations between social and structural determinants and outcomes are examined using multilevel models that respect the nesting of individuals within communities. Predictive epidemiological analytics developed to identify high-risk populations in other prevention domains illustrate transferable analytic approaches for this construct (Eweama et al., 2024). 7.2 Operationalizing Detection The detection construct is operationalized by evaluating identification technologies against the diagnostic and equity standards that responsible deployment demands. Diagnostic performance is quantified through sensitivity, specificity, and the area under the receiver operating characteristic curve, estimated against established reference standards such as twelve-lead electrocardiography, and reported separately by subgroup so that any inequity in performance is made visible rather than obscured within an aggregate. Operationalization further requires evaluation of whether detection translates into improved outcomes rather than merely increased diagnosis, achieved by linking detection to defined clinical pathways and measuring downstream effects. This distinguishes technologies ready for equitable population use from those requiring further development, and it directly addresses Propositions 2 and 5. 7.3 Operationalizing Delivery The delivery construct is operationalized through the dimensions and outcomes that implementation science has standardized. Evaluation is structured by the RE-AIM dimensions and complemented by implementation outcomes including acceptability, adoption, appropriateness, feasibility, fidelity, penetration, and sustainability (Proctor et al., 2011). Reach is assessed not only in absolute terms but with respect to representativeness, since a program that reaches many people but few of those at greatest need fails the framework's equity test. Effectiveness is measured against clinically meaningful outcomes, including the control of blood pressure, lipids, and glycemia and, where scale and duration permit, cardiovascular events, while disparity reduction is treated as a primary outcome in its own right. Cost and sustainability are assessed to ensure that delivery can be maintained and scaled beyond any period of dedicated support. 7.4 Testing the Framework The framework as a whole can be tested through designs that examine the relationships it posits rather than any single construct in isolation. Hybrid effectiveness-implementation designs, which collect data on both the outcomes of an intervention and the strategies and determinants of its delivery, are well suited to this purpose because they evaluate the detection-to-delivery linkage while accelerating the path from evidence to routine practice (Curran et al., 2012). The multiplicative relationship asserted in Proposition 1 can be examined by varying the strength of one construct while holding the others constant and observing whether population impact responds disproportionately; the feedback relationship of Proposition 4 can be examined by comparing systems that route outcome data back into measurement and detection against those that do not; and the equity dependence of Proposition 5 can be examined by tracking aggregate and subgroup outcomes in parallel. Because the framework's central commitments concern subgroups, evaluations that test it require attention to subgroup representation and, for community-delivered interventions, to the clustered structure of the data, so that the evidence generated is adequate to the equity questions the framework treats as primary. 7.5 An Illustrative Application To make the framework concrete, consider its application to hypertension, the most prevalent modifiable cardiovascular risk factor, within an underserved rural community. The measurement construct would first locate the burden, linking surveillance and electronic-record data to quantify local hypertension prevalence, control rates, and their social patterning, and to identify the subpopulations in which undiagnosed or uncontrolled disease concentrates. The detection construct would then extend identification beyond the sparse local clinic, deploying validated blood-pressure measurement and, where appropriate, wearable or single-lead screening through community settings and remote monitoring, with diagnostic performance verified to be comparable across the groups that measurement identified. The delivery construct would convert detection into action through community health workers and team-based care operating under shared protocols, linking each identified individual to titrated treatment and structured follow-up, and engaging local organizations to address the structural barriers that measurement revealed. Equity would be tracked throughout, by monitoring whether reach, detection performance, and improvements in control are distributed across subgroups rather than concentrated among the already advantaged. Finally, the feedback loop would return control rates and program data to measurement and detection, revealing, for example, that a particular subgroup is being reached but not controlled, and prompting recalibration of where and how detection and delivery are applied. The same logic extends to dyslipidemia, dysglycemia, and the integrated cardiovascular-kidney- metabolic continuum; hypertension serves here only as the clearest illustration of how the three constructs operate together. 8. Assumptions, Boundary Conditions, and Limitations 8.1 Algorithmic Fairness and Data Representation The framework's detection construct assumes the responsible deployment of algorithmic tools, and that assumption carries distinctive obligations that function as boundary conditions on the framework's claims. Algorithms learn the patterns present in their training data, and where that data underrepresents particular populations or encodes the inequities of the systems that generated it, the resulting models may perform unevenly or may propagate bias under the appearance of objectivity. A widely cited analysis showed how an algorithm used to manage population health systematically underestimated the needs of Black patients, illustrating how such bias can be embedded and then concealed within an ostensibly neutral tool (Obermeyer et al., 2019). A framework that treats equity as cross-cutting must therefore treat algorithmic fairness as a first- order requirement: training and validation data must adequately represent the diversity of the intended population; performance must be evaluated and reported by subgroup; and any disparity in performance must be addressed before deployment rather than discovered after it. The same applies to physiological sensing, where, for example, the performance of optical pulse sensing can vary with skin pigmentation and perfusion. Making these performance characteristics explicit and correcting for them is a condition of the framework's validity, not merely a technical refinement, and it is the substance of Proposition 5. Comparative analyses of artificial-intelligence governance in healthcare, spanning executive oversight, regulatory structures, and accountability across high- income and developing settings, underscore that these requirements are institutional as much as technical (Afrihyia et al., 2024a). 8.2 Privacy, Consent, and Data Governance Continuous physiological monitoring generates intimate, longitudinal data whose collection, storage, and use demand robust governance, and the framework's reach is bounded by the trustworthiness of that governance, as Proposition 6 makes explicit. The populations the framework most wishes to serve are frequently those with the greatest and most justified concerns about how their data may be used, and a failure to establish trustworthy governance would undermine both the ethics and the reach of the enterprise. Applying the framework therefore presupposes informed and meaningful consent, data minimization and security commensurate with the sensitivity of the information, transparency about how data inform clinical and research decisions, and governance structures that include the affected communities in decisions about the use of their data. These commitments are not in tension with the framework; they are conditions of its operation, because trust is a prerequisite for the participation on which both equity and valid evidence depend. Concrete approaches to meeting them exist, including privacy-preserving governance models that employ cryptographic and distributed-ledger techniques (Afrihyia et al., 2024b) and standards-compliant secure-analytics architectures designed for community healthcare organizations (Aliliele et al., 2024). 8.3 Limitations Several limitations bound the framework and warrant explicit acknowledgment. As a conceptual structure, the framework organizes and interprets existing evidence rather than supplying new empirical confirmation, and its propositions, while stated to be testable, await the systematic evaluation that Section 7 describes. The epidemiologic evidence on which it builds derives substantially from surveillance and observational data, which support inference about distribution and association but not, by themselves, about causation. The evidence base for the detection construct, while expanding rapidly, remains uneven in quality and has frequently been generated under supervised conditions that may not reflect real-world use, so that the framework's reliance on equitable real-world performance is an assumption to be verified rather than a fact to be presumed. Evidence relevant to the delivery construct is inherently context-bound, and relationships established in one set of settings may transfer imperfectly to others; the framework's grounding in established implementation theory improves transportability but does not guarantee it. Finally, the framework's central claim, that integration across constructs is the locus of impact, introduces coordination demands that are themselves a practical challenge to realization. These limitations do not undermine the framework, but they define the humility with which its claims are advanced and the rigor with which they must be tested. 9. Discussion The synthesis assembled in this paper supports a clear and, in some respects, uncomfortable conclusion. The cardiovascular burden persists not because the science of prevention is incomplete but because its fruits are distributed and delivered poorly, and because the populations that bear the greatest burden are precisely those that conventional, clinic-centered, episodic care reaches least well. The deceleration of the long decline in cardiovascular mortality, the adverse trajectories of obesity, hypertension, diabetes, and chronic kidney disease, the projection of a sharply rising burden through mid-century, and the stark and persistent disparities by race, ethnicity, sex, and geography together describe a problem that will not yield to incremental refinement of existing clinical pathways alone (Martin et al., 2025; American Heart Association, 2024). What the evidence also reveals is a genuine opportunity. Digital-health innovation has matured to the point where earlier and more accessible detection is technically feasible, with consumer wearables and artificial-intelligence-enhanced electrocardiography demonstrating capabilities that extend cardiovascular screening far beyond the clinic (Lubitz et al., 2022; Attia et al., 2019; Siontis et al., 2021). Implementation science has matured in parallel, supplying frameworks and delivery models, notably the community health worker approach, with demonstrated capacity to extend reach and improve control among underserved populations (Glasgow et al., 1999; Damschroder et al., 2009; Schwalm et al., 2019). The opportunity lies in the convergence of these maturing capabilities with the precision of contemporary epidemiology, and the argument of this paper is that capturing it requires their deliberate integration rather than their separate pursuit. The MDD framework proposed here is one response to that imperative. By organizing epidemiologic measurement, digital detection, and equitable delivery into a single structure linked by feedback, the framework aligns the discovery of where risk concentrates, the identification of it earlier and more widely, and the delivery of effective intervention to those who need it most. The emphasis on equity is not ornamental but structural: because the aggregate burden is sustained by disparity, a framework that improves performance for the most burdened groups is a framework that reduces the burden overall. The insistence on rigorous validation, subgroup-specific performance, and trustworthy data governance reflects the recognition that tools and interventions deployed at population scale must withstand demanding external scrutiny and must be verifiable in their claims, particularly when they touch the populations that have the strongest reasons for caution. Stated as propositions, these commitments become claims that can be tested and, if they fail, revised. Several implications follow for the broader field. First, prevention research should increasingly be designed for delivery from the outset, with implementation considerations built into study design rather than deferred to a later translational phase; because delivery capacity, and not intervention efficacy alone, determines whether prevention reaches the population, the translation of infrastructure investment into measurable population health and diagnostic outcomes is itself a legitimate object of study (Ogbete and Aminu-Ibrahim, 2024). Second, the evaluation of digital tools should center on equitable real-world performance and on the translation of detection into outcomes, not on technical accuracy in selected cohorts. Third, the measurement of disparity reduction deserves elevation to a primary outcome in prevention research, since aggregate measures can mask the divergent trajectories of advantaged and disadvantaged groups. These implications point toward a model of cardiovascular prevention that is anticipatory rather than reactive, distributed rather than clinic-bound, and equitable by design rather than by aspiration. 10. Conclusion Cardiovascular disease remains the leading cause of death, its burden is projected to grow, and that burden falls most heavily on the populations least well served by conventional care. The central argument of this paper is that the decisive constraint on further progress is no longer the absence of effective interventions but the failure to detect disease early enough and to deliver effective prevention widely and equitably enough. Meeting that constraint requires the integration of three disciplines that have too often advanced in isolation: epidemiology, which measures where risk concentrates; digital-health innovation, which can move detection earlier and extend its reach; and implementation science, which can deliver effective intervention durably and equitably at scale. The Measurement, Detection, and Delivery framework set out here gives that integration an explicit structure. It names the three constructs on which cardiovascular prevention depends, specifies their arrangement as a sequence linked by feedback, treats equity as a property that must hold across all of them, and states its claims as propositions that can be tested and revised rather than merely asserted. Its commitments are clear: to locate risk precisely in the populations that bear it most heavily; to identify disease earlier and more widely through tools held to demanding diagnostic and equity standards; to deliver effective intervention in real-world settings with disparity reduction as a primary concern; and to govern the use of algorithmic and remote- monitoring technologies in a manner that earns and sustains the trust of the communities they are meant to serve. Pursued together, these commitments describe a path toward a model of cardiovascular prevention that is earlier in its detection, broader in its reach, and fairer in its distribution than the one that prevails today. The burden documented throughout this paper is not a fixed feature of the population's future; it is the projection of present trends, and present trends can be changed. Advancing cardiovascular disease prevention through the disciplined integration of epidemiologic research, translational digital-health innovation, and scalable implementation frameworks offers a credible and defensible means of changing them, and of strengthening population health outcomes in a manner that reaches those who have waited longest for the benefits that prevention science has long been able to provide. References Aarons, G. A., Hurlburt, M., and Horwitz, S. M. (2011). Advancing a conceptual model of evidence-based practice implementation in public service sectors. Administration and Policy in Mental Health and Mental Health Services Research, 38(1), 4 to 23. Abah, M. A., Okwah, M. N., Oladosu, M. A., Yohanna, N. R., and Blessing, C. T. (2025b). Advances in the management of hypertension: a review of current guidelines, pharmacological therapies, and lifestyle interventions. Drug and Pharmaceutical Science Archives, 5(4), 35 to 41. https://doi.org/10.47587/DAP.2025.5401 Abah, M. A., Okwah, M. N., Oladosu, M. A., Yohanna, N. R., Blessing, C. T., and Vanessa, O. I. (2025a). The impact of lifestyle modifications on cardiovascular health: a review of diet, exercise, and stress reduction intervention. Drug and Pharmaceutical Science Archives, 5(3), 26 to 34. https://doi.org/10.47587/DAP.2025.5301 Adelanwa, A., Basnet, A., and Anene, U. N. (n.d.). Advanced AI-based decision support systems for healthcare operations and resource planning. Gyanshauryam, International Scientific Refereed Research Journal, 7(1). Afrihyia, E., Akinse, S. G., and Ojukwu, P. U. (2023). Development and implementation of an AI- driven early detection system for non-communicable diseases. International Journal of Advanced Multidisciplinary Research and Studies, 3(6), 2680 to 2691. Afrihyia, E., Akinse, S. G., and Ojukwu, P. U. (2024a). Comparative governance of AI-driven healthcare management: executive oversight, regulatory structures, and accountability in the United States and developing countries. International Journal of Advanced Multidisciplinary Research and Studies, 4(6), 3087 to 3102. https://doi.org/10.62225/2583049X.2024.4.6.5920 Afrihyia, E., Ojukwu, P. U., and Akinse, S. G. (2024b). Privacy-preserving health data governance models: a comparative review of blockchain and cryptographic strategies in U.S. and developing healthcare systems. International Journal of Advanced Multidisciplinary Research and Studies, 4(6), 3071 to 3086. https://doi.org/10.62225/2583049X.2024.4.6.5919 Akinse, S. G., Ekechi, N. V., and Ohanebo, C. G. (2023). Integrative maternal health model: addressing socioeconomic inequities in rural populations. International Journal of Advanced Multidisciplinary Research and Studies, 3(6), 2832 to 2838. Aliliele, C., Mbonu, I. S., and Iwuanyanwu, U. (2024). Advances in HIPAA compliant data architecture and secure analytics frameworks for community healthcare organizations. Shodhshauryam, International Scientific Refereed Research Journal, 7(2), 277 to 324. https://doi.org/10.32628/SHISRRJ2472163 Amadi, C. E., Akanbi, P. O., Okwah, M. N., Mbakwem, A. C., and Ajuluchukwu, J. N. (2026a). Triglyceride-glucose index and reduced kidney function in hypertensive Nigerian adults: independent association within the cardio-renal continuum. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-026-05985-5 Amadi, C. E., Ale, O. K., Okorafor, U. C., Okwah, M. N., Akanbi, P. O., Mbakwem, A. C., and Ajuluchukwu, J. N. (2026b). Unmasking the contemporary burden of hypertension in Lagos, Nigeria: insights from an opportunistic screening. BMC Public Health (article in press). https://doi.org/10.1186/s12889-026-26310-x Amadi, C. E., Okorafor, U. C., Okorafor, C. I., Okwah, M. N., Akanbi, P. O., Okam, O. V., Udenze, C. I., Mbakwem, A. C., and Ajuluchukwu, J. N. (2025). Association between triglyceride-glucose index and estimated 10-year risk of cardiovascular disease in Nigerian non-diabetic hypertensives: a cross-sectional study. PLOS Global Public Health, 5(7), e0004760. https://doi.org/10.1371/journal.pgph.0004760 American Heart Association. (2024). Forecasting the burden of cardiovascular disease and stroke in the United States through 2050: prevalence of risk factors and disease. A presidential advisory from the American Heart Association. Circulation, 150, e65 to e88. American Heart Association. (2024). Leveraging implementation science for cardiovascular health equity: a scientific statement from the American Heart Association. Circulation. Aminu-Ibrahim, A. Y., and Ogbete, J. C. (2023). Healthcare infrastructure as a public health intervention using evidence from large laboratory networks. Shodhshauryam, International Scientific Refereed Research Journal, 6(1), 256 to 286. https://doi.org/10.32628/SHISRRJ23678 Aminu-Ibrahim, A. Y., Ogbete, J. C., and Ambali, K. B. (2020). Infrastructure driven expansion of diagnostic access across underserved and rural healthcare regions. International Journal of Multidisciplinary Research and Growth Evaluation, 1(5), 691 to 706. https://doi.org/10.54660/IJMRGE.2020.1.5.691-706 Aminu-Ibrahim, A. Y., Ogbete, J. C., and Iwuanyanwu, O. C. (2025). Infrastructure resilience planning for national diagnostic systems under public health stress conditions. Gyanshauryam, International Scientific Refereed Research Journal, 8(1), 340 to 381. https://doi.org/10.32628/GISRRJ2582311 Anioke, S. C., Eweama, C. R., and Ohanebo, C. G. (2023). Advanced digital public health communication model for improving HIV testing uptake and prevention outcomes. Shodhshauryam, International Scientific Refereed Research Journal, 6(6), 336 to 379. https://doi.org/10.32628/SHISRRJ24799 Anioke, S. C., Eweama, C. R., and Ohanebo, C. G. (2024). Systematic review of structural and social determinants influencing HIV testing and treatment engagement. International Journal of Scientific Research in Humanities and Social Sciences, 1(2), 1126 to 1168. https://doi.org/10.32628/IJSRSSH242783 Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., et al. (2019). 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology and American Heart Association task force on clinical practice guidelines. Circulation, 140(11), e596 to e646. Atakpa, M. I., Abolaji, T. O., and Abetoh, N. F. (2024). Statistical time-series models for long- range public health trend forecasting: a review and conceptual framework. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 10(6), 2748 to 2780. https://doi.org/10.32628/CSEIT2410792 Atakpa, M. I., Abolaji, T. O., and Akeju, B. (2023). A review of natural language processing for social media-based public health surveillance and analytics. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 9(6), 1030 to 1060. https://doi.org/10.32628/CSEIT23906783 Attia, Z. I., Kapa, S., Lopez-Jimenez, F., McKie, P. M., Ladewig, D. J., Satam, G., et al. (2019). Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram. Nature Medicine, 25(1), 70 to 74. Curran, G. M., Bauer, M., Mittman, B., Pyne, J. M., and Stetler, C. (2012). Effectiveness- implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Medical Care, 50(3), 217 to 226. Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., and Lowery, J. C. (2009). Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implementation Science, 4, 50. Damschroder, L. J., Reardon, C. M., Widerquist, M. A. O., and Lowery, J. (2022). The updated Consolidated Framework for Implementation Research based on user feedback. Implementation Science, 17(1), 75. David, F. T., Abah, M. A., Oladosu, M. A., Agida, O. D., Clive, N. O., Adebukola, A. M., Nnabuko, O. M., and Maryanne, O. U. (2025). The impact of plant-based diets on cardiovascular health: a comprehensive review. Plant Science Archives, 10(4), 51 to 59. https://doi.org/10.51470/PSA.2025.10.4.51 Eweama, C. R., Anioke, S. C., and Ohanebo, C. G. (2019). Comprehensive review of global infectious disease preparedness frameworks for strengthening health system resilience. Iconic Research and Engineering Journals, 2(12), 637 to 665. https://doi.org/10.64388/IREV2I12-1715328 Eweama, C. R., Anioke, S. C., and Ohanebo, C. G. (2021). Predictive community-based disease surveillance model for early detection of epidemic threats. Shodhshauryam, International Scientific Refereed Research Journal, 4(2), 244 to 280. https://doi.org/10.32628/SHISRRJ214251 Eweama, C. R., Anioke, S. C., and Ohanebo, C. G. (2024). Advances in predictive epidemiological analytics for identifying high-risk populations in infectious disease prevention. International Journal of Scientific Research in Humanities and Social Sciences, 1(2), 1077 to 1125. https://doi.org/10.32628/IJSRSSH242782 Fehintola, F. O., Olugbade, T., Olowogoke, M. E., Okwah, M. N., Obawole, O. M., and Olunu, O. D. (2024). Theory of planned behaviour and intention to use condoms among adolescents in low-resource setting. Global Journal of Health Science, 16(9), 39. https://doi.org/10.5539/gjhs.v16n9p39 Feldstein, A. C., and Glasgow, R. E. (2008). A practical, robust implementation and sustainability model for integrating research findings into practice. Joint Commission Journal on Quality and Patient Safety, 34(4), 228 to 243. Frieden, T. R. (2010). A framework for public health action: the health impact pyramid. American Journal of Public Health, 100(4), 590 to 595. Glasgow, R. E., Vogt, T. M., and Boles, S. M. (1999). Evaluating the public health impact of health promotion interventions: the RE-AIM framework. American Journal of Public Health, 89(9), 1322 to 1327. Havranek, E. P., Mujahid, M. S., Barr, D. A., Blair, I. V., Cohen, M. S., Cruz-Flores, S., et al. (2015). Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 132(9), 873 to 898. Heart Failure Society of America. (2025). HF Stats 2025: heart failu